Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0EB9H
|
|||
| Former ID |
DNC013354
|
|||
| Drug Name |
3-ethoxy-5-(2-methylquinolin-7-yl)benzonitrile
|
|||
| Synonyms |
CHEMBL233358; 3-ethoxy-5-(2-methylquinolin-7-yl)benzonitrile
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H16N2O
|
|||
| Canonical SMILES |
CCOC1=CC(=CC(=C1)C2=CC3=C(C=CC(=N3)C)C=C2)C#N
|
|||
| InChI |
1S/C19H16N2O/c1-3-22-18-9-14(12-20)8-17(10-18)16-7-6-15-5-4-13(2)21-19(15)11-16/h4-11H,3H2,1-2H3
|
|||
| InChIKey |
QGNKITVJGNCQSU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Rational design of 7-arylquinolines as non-competitive metabotropic glutamate receptor subtype 5 antagonists. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4415-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.